Does OLAPARIB Cause Intestinal obstruction? 135 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Intestinal obstruction have been filed in association with OLAPARIB (Lynparza). This represents 0.7% of all adverse event reports for OLAPARIB.
135
Reports of Intestinal obstruction with OLAPARIB
0.7%
of all OLAPARIB reports
17
Deaths
90
Hospitalizations
How Dangerous Is Intestinal obstruction From OLAPARIB?
Of the 135 reports, 17 (12.6%) resulted in death, 90 (66.7%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which OLAPARIB Alternatives Have Lower Intestinal obstruction Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL